Metraipolis › archive › dc_bc7cd6c50795
Can the right to science redress inequitable access to innovative cancer therapy? A case for the justiciability of this 'lesser known' human right — Europe PMC PMID:40979625
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40979625
- DOI
- 10.1093/jlb/lsaf017
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T20:29:12.728Z
- SHA-256 of the archived text
0690a4b01e183488da6bfaff96766654ca690f65b0774a2e3cc99a63c83dd5e7- Stable URL of this page
https://metraipolis.com/documento/dc_bc7cd6c50795
How to cite
Can the right to science redress inequitable access to innovative cancer therapy? A case for the justiciability of this 'lesser known' human right — Europe PMC PMID:40979625 — Europe PMC (en), https://europepmc.org/article/MED/40979625 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc7cd6c50795 (Metraipolis archive dc_bc7cd6c50795, sha256 0690a4b01e183488da6bfaff96766654ca690f65b0774a2e3cc99a63c83dd5e7)
BibTeX
@misc{dcbc7cd6c50795,
title = {Can the right to science redress inequitable access to innovative cancer therapy? A case for the justiciability of this 'lesser known' human right — Europe PMC PMID:40979625},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40979625},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc7cd6c50795; sha256 0690a4b01e183488da6bfaff96766654ca690f65b0774a2e3cc99a63c83dd5e7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40979625. Agents can read the archived copy with the MCP tool read_document.